Pines que coinciden con tag:Guidance

Johnson & Johnson reported second-quarter sales of $25.3 billion, up 6.6%, and adjusted EPS of $2.90, and raised its 2026 outlook to about $101.1 billion in sales and $11.68 adjusted EPS at the midpoint.

TSMC reported second-quarter revenue of US$40.20 billion, up 33.7% from a year earlier, a 67.7% gross margin and record net income of NT$706.56 billion, guided Q3 revenue to US$44.6-45.8 billion and raised its 2026 capital budget to US$60-64 billion.

Abbott posted second-quarter sales of $12.59 billion, up 13.0% reported and 4.8% comparable, and adjusted EPS of $1.31, and raised its 2026 adjusted EPS guidance to $5.45 to $5.60.

HPE posted record fiscal third-quarter revenue of $12.2 billion, up 34%, and non-GAAP EPS of $1.11, then raised its fiscal 2026 and 2027 outlook as AI and networking orders ran ahead of memory-constrained supply.

Johnson & Johnson releases its third-quarter 2026 results at about 6:45 a.m. Eastern on Tuesday 13 October and reviews them on an 8:30 a.m. investor call hosted by CEO Joaquin Duato and CFO Joseph Wolk.

TSMC reports third-quarter 2026 results and gives its fourth-quarter outlook at its earnings conference on Thursday 15 October at 2 p.m. Taiwan time, against its own guidance of US$44.6-45.8 billion in revenue and a 65-67% gross margin.

Abbott is expected to report third-quarter 2026 results before the market opens and webcast its earnings call at 8 a.m. Central, most likely on Wednesday 21 October; it has guided to adjusted EPS of $1.38 to $1.46.

Se espera que Eli Lilly publique sus resultados del tercer trimestre de 2026 el 29 de octubre, con su habitual conferencia telefónica a las 10:00 h ET. Llega tras elevar su previsión de ingresos para 2026 a 85.000-87.000 millones de dólares, después de que los ingresos del segundo trimestre subieran un 48%, hasta 23.000 millones, impulsados por Mounjaro y Zepbound.

HPE is expected to report fiscal Q4 and full-year 2026 results after the close, most likely on Thursday 3 December, having guided to $13.9-14.8 billion of quarterly revenue and $1.20-1.30 of non-GAAP EPS; HPE has not yet announced the date.

Johnson & Johnson holds its first enterprise business review since December 2023, where CFO Joseph Wolk says it will set out growth above its 5% to 7% long-term target, with a clear line of sight to double digits by the end of the decade.